Short Summary
In a matter concerning the removal and rectification of trademarks, Sowkhya Way2 Health Private Limited filed two petitions against Dr. Isaac Mathai and others. However, citing a prior memorandum of compromise between the parties, the petitioner subsequently withdrew both petitions. The Madras High Court accepted the withdrawal, dismissing the cases without making any ruling on the merits or costs.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Madras High Court. Understanding the court's reasoning in Sowkhya Way2 Health Private Limited vs Dr.Isaac Mathai; Soukya Indian Holistic Centre Pvt. Ltd.; The Registrar of Trademarks is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
T.T.K.Pharma LimitedvsRobapharam Ag
The appeal was filed by T.T.K.Pharma Limited against an order refusing to stay a suit filed by Robapharam Ag regarding the registered Trade Mark "OSSOPAN". The appellant argued that a rectification application under the Trade and Merchandise Marks Act, 1958, had been filed. However, the court dismissed the appeal, finding no merit in the request for a stay.
Qualcomm IncorporatedvsController Of Patents And Designs
Qualcomm Incorporated appealed against the order of the Controller of Patents and Designs rejecting their patent application. The Madras High Court set aside the impugned order and remanded the matter for reconsideration, directing a different officer to undertake the re-examination. The court found the original order to be arbitrary and a colourable exercise of power. The patent application will now be re-examined, providing Qualcomm Incorporated with another opportunity to secure a patent.
Crocs Inc.UsavsAquallite India Limited And Anr.
The plaintiff alleged infringement of the design of its footwear, known as the 'CROCS DESIGN'. The design registration was cancelled due to lack of novelty and prior publication.
Novo Nordisk A/SvsDr Reddys Laboratories Limited & Anr.
Novo Nordisk appealed a rejection of its interlocutory injunction application regarding the import and sale of Semaglutide, claiming infringement of its patent. The court dismissed the appeal, noting that the suit patent was set to expire shortly, but also found prima facie evidence suggesting the suit patent could be challenged for obviousness based on prior art (Genus Patent IN'964).
Novartis Ag & Anr.vsNovarise Pharmachem Private Limited
The Delhi High Court granted an ad-interim injunction in favor of Novartis against Novarise Pharmachem Private Limited, addressing a trademark infringement dispute. The court found that the Plaintiffs had established a prima facie case regarding their registered trade mark 'NOVARTIS,' noting its extensive use and high goodwill in the pharmaceutical sector. Given the likelihood of consumer confusion between 'NOVARTIS' and 'NOVARISE,' the court restrained the defendant from manufacturing or selling products under the impugned mark until further hearing.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.